HS

Hergen Spits

AB Aimm Therapeutics B.V.: 13 patents #2 of 28Top 8%
ML Medimmune Limited: 4 patents #167 of 738Top 25%
SC Schering: 4 patents #698 of 2,442Top 30%
CL Cancer Research Technology Limited: 2 patents #198 of 493Top 45%
Overall (All Time): #129,420 of 4,157,543Top 4%
29
Patents All Time

Issued Patents All Time

Showing 1–25 of 29 patents

Patent #TitleCo-InventorsDate
12084681 Ex vivo antibody production Paula Maria Wilhelmina VAN HELDEN, Mark Jeroen Kwakkenbos, Tim Beaumont 2024-09-10
11999793 Therapeutic anti-CD9 antibody Paula Maria Wilhelmina VAN HELDEN, Remko Schotte, Wouter Pos, Christien FATMAWATI, Danïel Michiel GO +2 more 2024-06-04
11629200 Means and methods for counteracting myeloproliferative or lymphoproliferative disorders Tim Beaumont, Marijn Aletta GILLISSEN, Adrianus Q. Bakker, Mette Deborah Hazenberg, Martijn KEDDE 2023-04-18
11524989 AML antigens and uses thereof Marijn Aletta GILLISSEN, Martijn KEDDE, Mette Deborah Hazenberg, Paula Maria Wilhelmina VAN HELDEN, Wouter Pos 2022-12-13
11136407 Therapeutic anti-CD9 antibody Paula Maria Wilhelmina VAN HELDEN, Remko Schotte, Wouter Pos, Christien FATMAWATI, Danïel Michiel GO +2 more 2021-10-05
10774308 Means and methods for influencing the stability of cells 2020-09-15
10730931 RSV-specific binding molecules and means for producing them Tim Beaumont, Mark Jeroen Kwakkenbos, Etsuko Yasuda 2020-08-04
10690658 Means and methods for determining T cell recognition Carsten Linnemann, Laura Bies, Marit M. VAN BUUREN, Antonius Nicolaas Maria Schumacher, Remko Schotte 2020-06-23
10556963 Means and methods for counteracting myeloproliferative or lymphoproliferative disorders Tim Beaumont, Marijn Aletta GILLISSEN, Adrianus Q. Bakker, Mette Deborah Hazenberg, Martijn KEDDE 2020-02-11
10344076 Means and methods for producing high affinity antibodies Tim Beaumont, Mark Jeroen Kwakkenbos, Adrianus Q. Bakker 2019-07-09
10273454 Means and methods for influencing the stability of antibody producing cells Ferenc A. Scheeren, Tim Beaumont, Sean A. Diehl 2019-04-30
10077427 Means and methods for influencing the stability of cells 2018-09-18
10059757 RSV-specific binding molecules and means for producing them Tim Beaumont, Mark Jeroen Kwakkenbos, Etsuko Yasuda 2018-08-28
9969795 Means and methods for producing high affinity antibodies Tim Beaumont, Mark Jeroen Kwakkenbos, Adrianus Q. Bakker, Koen Wagner 2018-05-15
9822339 Means and methods for influencing the stability of antibody producing cells Ferenc A. Scheeren, Tim Beaumont, Sean A. Diehl 2017-11-21
9718874 Influenza A virus specific antibodies Tim Beaumont, Mark Jeroen Kwakkenbos, Arjen Quirinus Bakker 2017-08-01
9321831 RSV-specific binding molecules and means for producing them Tim Beaumont, Mark Jeroen Kwakkenbos, Etsuko Yasuda 2016-04-26
9273118 Means and methods for producing high affinity antibodies Tim Beaumont, Mark Jeroen Kwakkenbos, Adrianus Q. Bakker 2016-03-01
9206247 Means and methods for producing high affinity antibodies Tim Beaumont, Mark Jeroen Kwakkenbos, Adrianus Q. Bakker, Koen Wagner 2015-12-08
9127251 Means and methods for influencing the stability of antibody producing cells Ferenc A. Scheeren, Tim Beaumont, Sean A. Diehl 2015-09-08
9005974 Means and methods for influencing the stability of cells 2015-04-14
8562996 RSV-specific binding molecules and means for producing them Tim Beaumont 2013-10-22
8389281 Materials and methods relating to the production and maintenance of cell lines Marianne Naspetti, Ferenc A. Scheeren, Bianca Blom 2013-03-05
8318487 Materials and methods relating to the production and maintenance of cell lines Marianne Naspetti, Ferenc A. Scheeren, Bianca Blom 2012-11-27
7964406 Means and methods for producing a stabilized cell of interest Benjamin Berkhout, Jurgen E. Seppen, David M. Markusic, Kees Weijer 2011-06-21